课题基金 / 基金详情

Research Conference--Protein Kinases and Phosphorylation

Research Conference--Protein Kinases and Phosphorylation
研究会议--蛋白激酶和磷酸化
批准号:
6776956
负责人:
TONY R. HUNTER
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2006-07-31

项目摘要

项目成果

TONY R. HUNTER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (proved by applicant): This application is for partial funding for the 2001 FASEB conference on Protein Kinases and Phosphorylation. The meeting will be held in Snowmass, Colorado, Saturday July 24 to Thursday, July 29, 2001. This conference is generally considered to be the premiere bi-annual meeting on protein kinase research and brings together 43 speakers and more than two hundred research scientists. The conference will cover many aspects of protein kinase biochemistry, cell and physiological function, pharmacology, and target these enzymes inside the cell. The 2001 meeting will focus on emerging topics of kinase research and will center around the themes of: kinases/phosphatases involved in metabolism and disease, kinase/phosphatase regulatory mechanisms, MAP kinase signaling complexes, kinase/phosphatase structure-function analysis, small molecule inhibitors, imaging of phosphorylation events, kinases/phosphatase regulation of transcription, developmental fate, the cytoskeleton, and cell cycle regulation. The opening lecture will be given by Dr. John Scott. Dr. Scott has completed much of the pioneering work on the identification of protein modules such as SH2 and SH3 domains that govern the assembly of multienzyme signal transduction complexes. The keynote address will be given by Dr. Jack Dixon, who has conducted much of the early work on understanding the role of protein lipid phosphatases in normal and disease physiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative and Biostatistics Core
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
Histidine phosphorylation as a new target for cancer therapy